Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Synairgen Share Price
  4. Synairgen Share Regulatory News
  5. Holding(s) in Company

Pin to quick picksSynairgen Regulatory News (SNG)

Synairgen Information

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.08 (1.31%)
Spread: 1.48 (26.812%)
Open: 6.20
High: 6.20
Low: 6.20
Prev. Close: 6.12
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Mar 2022 16:35

RNS Number : 0818E
Synairgen plc
08 March 2022
 

 

Synairgen plc

 

("Synairgen" or the "Company")

 

Holding(s) in Company

 

Synairgen was informed on 8 March 2022 that Polar Capital LLP no longer has a disclosable interest in the Company.

 

For further information, please contact:

 

Synairgen plc 

Richard Marsden, Chief Executive Officer

John Ward, Chief Financial Officer

Brooke Clarke, Head of Communications

Tel: +44 (0) 23 8051 2800

 

finnCap (NOMAD and Joint Broker)

Geoff Nash, Kate Bannatyne, Charlie Beeson (Corporate Finance)

Alice Lane, Sunil de Silva (ECM)

Tel: +44 (0) 20 7220 0500

 

Numis Securities Limited (Joint Broker)

James Black, Freddie Barnfield, Duncan Monteith

Tel: +44 (0) 20 7260 1000

 

Consilium Strategic Communications (Financial Media and Investor

Relations)

Mary-Jane Elliott, Jessica Hodgson, Lucy Featherstone

synairgen@consilium-comms.com

Tel: +44 (0) 20 3709 5700

 

MK Strategies, LLC (US Media Relations)

Mary Conway

MConway@MKCStrategies.com

Tel: +1 516 606 6545

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFVRVLITIIF
12345678910
Date   Source Headline
22nd Apr 20155:03 pmRNSPosting of Annual Report and Accounts
5th Mar 201512:55 pmRNSRichard Griffiths increases stake to 6.1 percent
3rd Mar 20157:00 amRNSPreliminary Results
12th Feb 201512:44 pmRNSHolding(s) in Company
11th Nov 20142:34 pmRNSExercise of options
4th Nov 20147:00 amRNSGrant of Options
8th Oct 20147:00 amRNSExercise of options
25th Sep 20147:00 amRNSInterim results for the six months ended 30 June
17th Sep 20147:00 amRNSNotice of Interim Results
22nd Jul 20145:23 pmRNSHolding(s) in Company
22nd Jul 201411:11 amRNSHolding(s) in Company
22nd Jul 201411:08 amRNSHolding(s) in Company
21st Jul 20143:53 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSHolding(s) in Company
15th Jul 20143:13 pmRNSHolding(s) in Company
4th Jul 20142:44 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSPlacing
25th Jun 20147:00 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSLicence deal with AstraZeneca
9th Jun 20141:00 pmRNSResult of AGM
16th May 20147:00 amRNSNotice of AGM
9th May 20142:57 pmRNSNotice of Report and Accounts
20th Mar 20147:00 amRNSPreliminary Results
11th Mar 20145:05 pmRNSHolding(s) in Company
6th Mar 201412:58 pmRNSHolding(s) in Company
5th Mar 20147:00 amRNSLicensing Update, Placing & Notice of results
14th Oct 20139:05 amRNSExercise of Options
12th Aug 20137:00 amRNSHalf Yearly Report
18th Jul 20137:00 amRNSPositive anti-inflammatory and anti-viral data
3rd Jul 20133:05 pmRNSHolding(s) in Company
10th Jun 20131:45 pmRNSResult of AGM
21st May 201311:10 amRNSHolding(s) in Company
9th May 201312:45 pmRNSNotice of AGM
9th Apr 20134:26 pmRNSPosting of Annual Report
12th Mar 20137:00 amRNSGrant of Options
13th Feb 20137:00 amRNSPreliminary Results
5th Dec 20127:00 amRNSTrading Update
30th Oct 20121:44 pmRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSExercise of Options
31st Aug 20127:00 amRNSSynairgen presents proof of concept study
10th Aug 20127:00 amRNSHalf Yearly Report
18th Jul 20127:00 amRNSPlacing
25th Jun 20121:30 pmRNSResult of AGM
22nd May 20127:30 amRNSProfessor Stephen Holgate given prestigious Award
1st May 201212:55 pmRNSHolding(s) in Company
19th Apr 20127:00 amRNSPositive Phase II asthma data
2nd Mar 20127:00 amRNSNotice of Report and Accounts
1st Feb 20127:00 amRNSPreliminary results
30th Jan 20127:00 amRNSNotice of Results
12th Dec 20117:00 amRNSDirector's dealing
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.